An interventional study of Intracranial macro-microelectrode recording in Focal Epilepsy, Electrodes, Implanted and Cognitive Function, sponsored by Institut National de la Santé Et de la Recherche Médicale, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-28.
Sponsored by Institut National de la Santé Et de la Recherche Médicale, France · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Epilepsies, Partial with a site in France — 11 open to participants now, 12 under way, 2 of them phase 3. Epilepsies, Partial · France.
Among the 40 studies in Epilepsies, Partial with a site in France, this one is the 21st largest by planned enrollment of the 27 interventional ones that give a count, is one of 2 that started in 2021, is one of 6 with no phase, reaches primary completion later than 8 of the 11 other live ones, and was the 29th registered.
243 studies on the registry are indexed under Epilepsies, Partial; 49 are open to participants now.
Browse Epilepsies, Partial studies →11 of the 40 studies in Epilepsies, Partial with a site in France are open now. Recruiting first, the newest first:
Fondation Ophtalmologique Adolphe de Rothschild · Sites in France
Ages 6–50
University Hospital, Lille · Sites in France
Ages 18–80
University Hospital, Bordeaux · Sites in France
Ages 18–65
University Hospital, Tours · Sites in France
Ages 1–18
University Hospital, Grenoble · Sites in France
Ages 18–65
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 37 Epilepsies, Partial studies recruiting now, 9 (24%) set no upper age limit and 24 (65%) stop at 75 or younger; 17 take children under 18; 3 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 12 · Phase 4 4
First in 1998; this study’s year is marked. 2 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 90 across 187 interventional studies indexed under Epilepsies, Partial.
Median enrollment 157 across the 27 interventional studies, 102 across the 13 observational. Of the 24 that completed or were terminated, 10 (42%) have results posted.
This tab as a report to print or save as PDF → With an account.
19 of 40 have an industry lead sponsor. The 10 most frequent:
Institut National de la Santé Et de la Recherche Médicale, France is the lead sponsor of 378 studies on the registry; 81 are open to participants now.
Institut National de la Santé Et de la Recherche Médicale, France has 2 studies filed under Epilepsies, Partial — fewer than ten, so there is no comparison to draw.
4 of the studies in Epilepsies, Partial with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06132893Phase 3Biohaven Therapeutics Ltd.A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy | 2026-12 |
| NCT06443463Biohaven Therapeutics Ltd.Long-term Safety and Tolerability of BHV-7000 | 2026-12 |
| NCT02890641Fondation Ophtalmologique Adolphe de RothschildGenetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies | 2026-12 |
| NCT06466681University Hospital, LilleChanges in Attentional Control After a Focal Seizure. | 2027-03-09 |
Add all 4 to your calendar (.ics) → With an account.
Among the 40 studies in Epilepsies, Partial with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main goal of this project is to study the mechanisms of epileptic activities using intracranial macro and micro electrodes in epileptic patients undergoing pre-surgical investigation.
The recordings will also be used to study physiological mechanisms like sleep and different cognitive functions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Implantation of macro-micro electrodes of the Adtech Benkhe-Fried type in epileptic patients who are undergoing evaluation with intracranial EEG electrodes
Device: Intracranial macro-microelectrode recording
Additionnally to clinical macroelectrodes, Benkhe-Fried depth macro-microelectrodes will be implanted and recorded during the pre-surgical investigation of epileptic patients
Identification of single unit changes at seizure emergence
In order to identify biomarkers of epileptic seizures we will study single neuron activities (firing rate) using spike sorting at different time periods (before, during and after seizures and during interictal periods) We expect to observe significant changes in firing rate across the different time periods.
Time frame: Whole duration of the clinical inverstigation, until 4 weeks
Identification of local field potential (LFP) changes at seizure emergence
In order to identify biomarkers of epileptic seizures we will study LFP power using time frequency analysis at different time periods (before, during and after seizures and during interictal periods) We expect to observe significant changes in LFP power across the different time periods.
Time frame: Whole duration of the clinical inverstigation, until 4 weeks
Comparison of single unit activity before seizure according to brain localization
We will compare firing rate before seizure according to brain regions (anatomy and involvement in the seizure onset zone)
Time frame: Whole duration ofthe clinical inverstigation, until 4 weeks
Identification of single unit changes during physiological brain activity
We will compare firing rates during resting states and stimulus induced states. We expect to observe significant changes in firing rate between states.
Time frame: Whole duration ofthe clinical inverstigation, until 4 weeks
Identification of LFP power changes during physiological brain activity
We will compare LFP power during resting states and stimulus induced states. We expect to observe significant changes in LFP power between states.
Time frame: Whole duration ofthe clinical inverstigation, until 4 weeks
Multilevel study of brain activity
We will look for correlation between firing rates and LFP power changes.
Time frame: Whole duration ofthe clinical inverstigation, until 4 weeks
Started Feb 2021 (actual). Primary completion is estimated for Feb 2029, 95 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut National de la Santé Et de la Recherche Médicale, France →